Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

ALK-Abelló A/S

AKBLFPNK
Healthcare
Biotechnology
$36.10
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

ALK-Abelló A/S (AKBLF) Stock Overview

Explore ALK-Abelló A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.3B
P/E Ratio42.31
EPS (TTM)$0.79
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$37.29
3 Months$42.88
1 Year Target$43.20

AKBLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ALK-Abelló A/S (AKBLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $43.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 42.31 and a market capitalization of 7.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
4.18%
6-Month Change
24.70%
Year-to-Date (YTD) Change
N/A
1-Year Change
69.09%
3-Year Change
157.86%
5-Year Change
72.73%
All-Time (Max) Change
671.37%

Contact Information

45 45 74 75 76
Boge Alle 6-8, Horsholm, NaN, 2970

Company Facts

27,360 Employees
IPO DateNov 16, 2009
CountryDK
Actively Trading

Frequently Asked Questions